Bando K, Turrentine M W, Sharp T G, Sekine Y, Aufiero T X, Sun K, Sekine E, Brown J W
Section of Cardiothoracic Surgery, James W. Riley Hospital for Children and Indiana University Medical Center, Indianapolis 46202-5123, USA.
J Thorac Cardiovasc Surg. 1996 Dec;112(6):1600-7; discussion 1607-9. doi: 10.1016/S0022-5223(96)70019-3.
Management of pulmonary hypertension, a potentially fatal complication of operations to correct congenital heart disease, has evolved through the last 15 years. Monitoring of pulmonary arterial pressure and mixed venous saturation became available, and prophylactic use of alpha-blockers and other vasodilators increased. This study examines risk factors for morbidity and mortality from pulmonary hypertension after operations to correct congenital heart disease and evaluates the impact of management changes on outcomes.
By means of multivariable logistic regression analysis, 880 high-risk patients with congenital heart disease (of 2484 patients undergoing cardiopulmonary bypass between January 1980 and December 1994) were analyzed to determine which were at risk for postoperative pulmonary hypertension and its associated morbidity and mortality.
Patients with atrioventricular canal (n = 182), truncus arteriosus (n = 47), total anomalous pulmonary venous connection (n = 90), transposition of great arteries (n = 97), hypoplastic left heart syndrome (n = 50), and ventricular septal defect (n = 414) demonstrated a higher risk of postoperative pulmonary hypertension. By multivariable logistic regression, preoperative pulmonary hypertension (p < 0.0001), absence of mixed venous saturation monitoring (p < 0.0001), and absence of prophylactic alpha-blockade (p = 0.0004) significantly increased postoperative pulmonary hypertension. Preoperative pulmonary hypertension (p < 0.001) and absence of prophylactic alpha-blockers (p = 0.0004) were significant risk factors for in-hospital death related to pulmonary hypertension. Repair at older age (except in the case of total anomalous pulmonary venous connection) was a significant risk for postoperative pulmonary hypertension (p = 0.03).
Mixed venous saturation monitoring and alpha-receptor blockade reduced the incidence of pulmonary hypertension after operations for congenital heart disease. Early definitive repair reduced morbidity and mortality from postoperative pulmonary hypertension.
肺动脉高压是先天性心脏病手术潜在的致命并发症,在过去15年中其治疗方法不断演变。肺动脉压和混合静脉血氧饱和度监测得以应用,α受体阻滞剂和其他血管扩张剂的预防性使用有所增加。本研究探讨先天性心脏病手术后肺动脉高压导致发病和死亡的危险因素,并评估治疗方法的改变对预后的影响。
通过多变量逻辑回归分析,对1980年1月至1994年12月期间接受体外循环的2484例患者中的880例高危先天性心脏病患者进行分析,以确定哪些患者有术后肺动脉高压及其相关发病和死亡的风险。
房室通道(n = 182)、动脉干(n = 47)、完全性肺静脉异位连接(n = 90)、大动脉转位(n = 97)、左心发育不全综合征(n = 50)和室间隔缺损(n = 414)的患者术后发生肺动脉高压的风险较高。通过多变量逻辑回归分析,术前肺动脉高压(p < 0.0001)、未进行混合静脉血氧饱和度监测(p < 0.0001)和未进行预防性α受体阻滞(p = 0.0004)显著增加术后肺动脉高压的发生风险。术前肺动脉高压(p < 0.001)和未使用预防性α受体阻滞剂(p = 0.0004)是与肺动脉高压相关的院内死亡的显著危险因素。年龄较大时进行修复(完全性肺静脉异位连接除外)是术后肺动脉高压的显著危险因素(p = 0.03)。
混合静脉血氧饱和度监测和α受体阻滞降低了先天性心脏病手术后肺动脉高压的发生率。早期确定性修复降低了术后肺动脉高压导致的发病率和死亡率。